InnoCare gets approval of clinical trial of Zurletrectinib for the treatment of pediatric patients in China
Zurletrectinib was developed to treat advanced or metastatic solid tumors harboring NTRK fusion genes
Zurletrectinib was developed to treat advanced or metastatic solid tumors harboring NTRK fusion genes
Through the use of robotic assisted orthopaedic surgeries, the success rate is close to 98%
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
AIIMS established in Bilaspur, Nagpur, Rae Bareli and Gorakhpur
Health-tech startups have the potential to revolutionize the healthcare sector by supporting innovations
1. 10 crore teleconsultations have been rendered to senior citizens and 5,22,15,224 to women
Traditional medicine effectively highlighted in all health and engagement working groups meeting and Ministry of Ayush acknowledges these efforts
The net profit in the June quarter was also lower than Rs 146.3 crore reported in the March quarter.
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
Subscribe To Our Newsletter & Stay Updated